Promising new treatment for drug-resistant prostate cancer
January 12, 2021Manufacturing and Production Cancer
A new experimental drug could offer a promising treatment strategy for men with advanced, drug-resistant prostate cancer, researchers have said. …
Purespring Therapeutics to appoint Richard Francis as CEO
January 11, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial
January 11, 2021Sales and Marketing Alzheimer's, Eli Lilly
Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …
Roche’s influenza drug Xofluza gets EU approval
January 11, 2021Sales and Marketing EC, Roche, influenza
The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …
MaxCyte signs licensing deal with Myeloid Therapeutics
January 11, 2021Sales and Marketing MaxCyte, Myeloid Therapeutics
MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …
Sanofi to acquire Kymab for $1.1bn
January 11, 2021Sales and Marketing Malin, Sanofi, kymab
Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …
Seven mass vaccination sites open in England
January 11, 2021Sales and Marketing COVID-19, UK, Vaccine
Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …
Pharmafile.com’s top 10 news stories of the week
January 8, 2021Medical Communications
Almost all of Pharmafile.com’s most popular stories this week focused on developments in the global mission to vaccinate against COVID-19. …
Pfizer’s COVID-19 vaccine protects against variants, research shows
January 8, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …
Bayer and CureVac to collaborate on COVID-19 vaccine candidate
January 8, 2021Medical Communications Bayer, COVID-19, Vaccine
Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …
Birmingham research paves way for new anti-fibrotic glaucoma treatment
January 8, 2021Medical Communications Glaucoma, University of Birmingham
New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …
Arthritis drugs could save lives of COVID-19 patients, study finds
January 8, 2021Medical Communications COVID-19
Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …
NICE recommends AstraZeneca’s FORXIGA for heart failure
January 7, 2021AstraZeneca, NICE
NICE has issued a positive Final Appraisal Document (FAD) recommending AstraZeneca’s FORXIGA (dapagliflozin) as an option for treatment of symptomatic …
New COVID-19 screening hub to be established in Scotland
January 7, 2021COVID-19
A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …
Bolivia registers Russia’s Sputnik V COVID-19 vaccine
January 7, 2021COVID-19, Vaccine
Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …
Fujifilm to invest $2bn in new US cell culture production site
January 7, 2021Fujifilm Diosynth Biotechnologies
Fujifilm has announced it is investing $2 billion to establish a new large-scale cell culture production site in the US. …
EU approves Moderna’s COVID-19 vaccine
January 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
Pharmafile.com’s weekly COVID-19 news round-up
January 6, 2021Research and Development COVID-19, Vaccine
In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
WHO recommends against 12-week delay for COVID-19 vaccine doses
January 6, 2021Research and Development COVID-19, Vaccine, WHO
The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
Biogen’s IM Plegridy gets EU approval
January 6, 2021Research and Development Biogen, multiple sclerosis
The European Commission has approved Biogen’s Plegridy (peginterferon beta-1a), a new intramuscular (IM) injection for the treatment of relapsing-remitting multiple …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
